Düsseldorf, Germany

Ru Angelie Edrada

This inventor holds 1 USPTO granted patent. Top assignee: Biotecmarin Gmbh. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ru Angelie Edrada. Retrieved from https://idiyas.com/inventor/ru-angelie-edrada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ru Angelie Edrada: Innovator in Decalactones and Pharmaceuticals

Introduction

Ru Angelie Edrada is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on decalactones. Her research and inventions have the potential to impact various medical applications.

Latest Patents

Ru Angelie Edrada holds a patent for "Decalactones, method for making, and pharmaceuticals there from." This patent discloses a novel class of decalactones characterized by a general formula (I) and their stereoisomers. The patent also describes a method for synthesizing these decalactones and their use in pharmaceutical compositions. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Edrada is currently associated with Biotecmarin GmbH, where she continues to advance her research in pharmaceuticals. Her work at the company emphasizes the importance of innovative solutions in the healthcare sector.

Collaborations

Throughout her career, Ru Angelie Edrada has collaborated with notable professionals in her field, including Peter Prokosch and Gerhard Bringmann. These collaborations have enriched her research and contributed to her success as an inventor.

Conclusion

Ru Angelie Edrada is a trailblazer in the development of decalactones and their pharmaceutical applications. Her contributions to the field are noteworthy and reflect her dedication to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…